Dr. Ciafaloni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
# 320
Rochester, NY 14642Phone+1 585-275-2559Fax+1 585-273-1255- Is this information wrong?
Education & Training
Duke University HospitalResidency, Neurology, 1996 - 1998
University of Milan Faculty of MedicineClass of 1989- Duke University HospitalFellowship, Neuromuscular Medicine (Neurology)
Certifications & Licensure
NY State Medical License 2002 - 2026
NC State Medical License 1999 - 2003
VA State Medical License 2001 - 2002- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Start of enrollment: 2006 Jun 01
- Characteristics of Andersen-Tawil Syndrome Start of enrollment: 2007 Nov 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report.Scharf, R. J., Niki Armstrong, Susan Apkon, Kiera N Berggren, Catherine Braun, Emma Ciafaloni, Anne Connolly, Annie Kennedy, Nancy Kuntz, Katherine Mathews, Michelle M...> ;Journal of Neuromuscular Diseases. 2024 Jan 1
- Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy.Kristin M Conway, Shiny Thomas, Emma Ciafaloni, Rabia S Khan, Joshua R Mann, Paul A Romitti, Katherine D Mathews> ;Birth Defects Research. 2024 Jan 1
- 3 citationsSafety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.Pedro M Machado, Michael P McDermott, Thomas Blaettler, Claus Sundgreen, Anthony A Amato, Emma Ciafaloni, Miriam Freimer, Summer B Gibson, Sarah M Jones, Todd D Levine...> ;The Lancet. Neurology. 2023 Oct 1
- Join now to see all
Journal Articles
- Implementation of Duchenne Muscular Dystrophy Care ConsiderationsEmma Ciafaloni, Christopher Cunniff, AAP News
Authored Content
- Implementation of Duchenne Muscular Dystrophy Care ConsiderationsJuly 2018
Press Mentions
Recommendations for Clinical Trial Design in Duchenne Muscular Dystrophy: Emma Ciafaloni, MDOctober 2nd, 2022
COVID-19: Guidelines for Myasthenia Gravis Management and Other Neuromuscular DisordersMay 21st, 2020
Where There Is Debate on the ‘Persuasive Evidence’ That Exon-Skipping Therapies Work for Duchenne Muscular DystrophyAugust 15th, 2019- Join now to see all
Grant Support
- Trial To Assess The Efficacy &Safety Of MMF In Subjects With Myasthenia GravisNational Center For Research Resources2005
- Causes Of Excessive Sleepiness In Myotonic DystrophyNational Center For Research Resources2004–2005
- A Clinical Trial Of Cellcept In The Treatment Of Myasthenia GravisNational Center For Research Resources2004–2005
Professional Memberships
- Member
Hospital Affiliations
Highland HospitalRochester, New York
Rochester General HospitalRochester, New York
Strong Memorial Hospital of the University of RochesterRochester, New York
Canandaigua Veterans Affairs Medical CenterCanandaigua, New York
Bath Veterans Affairs Medical CenterBath, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
